Cargando…
Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
BACKGROUND: There are limited data on uninterrupted anticoagulation with direct oral anticoagulants during catheter ablation for atrial fibrillation (AF), particularly in Japan. We planned a subgroup analysis of the RE‐CIRCUIT study, comparing the use of uninterrupted dabigatran therapy with warfari...
Autores principales: | Yoshida, Yukihiko, Watarai, Masato, Fujii, Kenshi, Shimizu, Wataru, Satomi, Kazuhiro, Inden, Yasuya, Murakami, Yoshimasa, Murakami, Masato, Iwasa, Atsushi, Kimura, Masaomi, Yamada, Nobuko, Nakagawa, Tomofumi, Nordaby, Matias, Okumura, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891433/ https://www.ncbi.nlm.nih.gov/pubmed/29657590 http://dx.doi.org/10.1002/joa3.12024 |
Ejemplares similares
-
Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study
por: Calkins, Hugh, et al.
Publicado: (2019) -
The Discovery of Dabigatran Etexilate
por: van Ryn, Joanne, et al.
Publicado: (2013) -
Dabigatran etexilate tetrahydrate
por: Liu, Hong-Qiang, et al.
Publicado: (2012) -
Uninterrupted dabigatran is safer than warfarin in patients undergoing
ablation for atrial fibrillation
por: Spartalis, Michael, et al.
Publicado: (2017) -
Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study
por: Hohnloser, Stefan H., et al.
Publicado: (2019)